Your session is about to expire
← Back to Search
Scaffold
MIACH Scaffold for ACL Tear (BEAR Trial)
N/A
Waitlist Available
Led By Lyle Micheli, MD
Research Sponsored by Miach Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3-months post-op
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a new device for repairing a torn ACL. 10 patients will use the new device, and 10 will have standard ACL surgery.
Who is the study for?
This trial is for individuals with a complete ACL tear confirmed by MRI, and the injury must have occurred within the last 90 days. Participants should still have some ACL tissue visible on pre-operative MRI.
What is being tested?
The study compares a new device called MIACH Scaffold used in repairing torn ACLs against standard ACL reconstruction surgery. It will involve 10 people getting the new treatment and another 10 receiving traditional surgery.
What are the potential side effects?
While specific side effects are not listed, they may include typical surgical risks such as pain at the site, infection, swelling, bleeding, or adverse reactions to anesthesia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 3-months post-op
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3-months post-op
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Safety and tolerability of the BEAR® Implant
Secondary study objectives
Anteroposterior (AP) knee laxity
Excessive Pain
Implant failure
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ACL repair with MIACH scaffoldExperimental Treatment1 Intervention
Patients will undergo ACL repair surgery using the newly developed MIACH scaffold
Group II: Standard ACL reconstructionActive Control1 Intervention
Patients will undergo a standard ACL reconstruction surgery
Find a Location
Who is running the clinical trial?
Miach OrthopaedicsLead Sponsor
4 Previous Clinical Trials
1,300 Total Patients Enrolled
2 Trials studying Anterior Cruciate Ligament Tear
300 Patients Enrolled for Anterior Cruciate Ligament Tear
Martha Murray, MDStudy DirectorBoston Children's Hospital
Lyle Micheli, MDPrincipal InvestigatorBoston Children's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: ACL repair with MIACH scaffold
- Group 2: Standard ACL reconstruction
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger